Skip to content
Search

Latest Stories

Exploring the Study of Peptides in Gut Function

This all-encompassing guide delves into the most recent breakthroughs in animal-based research studies focusing on peptides that may have the potential to improve gut function, besides the following:

  • Possibly lowering the inflammation in the intestines
  • Possibly facilitating the repair and regeneration of the gut
  • Possibly preventing the development of ulcers

Explore gut function and peptide research as this article delves into the mechanisms, potential, and properties of the most noteworthy peptide-based adjuvants. Learn more about these compounds by reading this article.


BPC-157 Peptide

BPC-157 is a pentadecapeptide synthesized in the 1990s. It is known amongst researchers for its purported potential to promote healing in various tissues, including the gastrointestinal tract. It has been hypothesized to interact with vasodilators, growth factors, vascularization, and neurotransmitter receptors. It has been speculated that BPC-157 may enhance the healing process after gastrointestinal surgery (anastomosis healing), alleviate short bowel syndrome, and protect against ulcers.

KPV Peptide

KPV, which stands for lysine-proline-valine, is a portion of alpha-melanocyte-stimulating hormone (alpha-MSH) located in the C-terminal region. It may have anti-inflammatory properties in various tissues, including digestive tract cell cultures and murine colitis models. According to the theory, it seems to do this by inhibiting the multiplication of immune cells and the production of inflammatory mediators. Research indicates a reduction in inflammation in inflammatory bowel disease (IBD), including ulcerative colitis examples.

VIP Peptide

It is believed that Vasoactive Intestinal Peptide (VIP), which is a naturally occurring peptide consisting of 28 residues and belonging to the secretin/glucagon family, is a neurotransmitter that might control some of the processes of the gut, such as acid secretion and motility. It was discovered in 1970 and is generated by nerve and immune cells. It has been theorized to act on the digestive system as well as other parts of the body. Studies suggest that it may have an anti-inflammatory effect, making it a possible research candidate in the context of colitis.

Research Peptides: What are they?

Research suggests that peptides are important chemical compounds found in all living creatures. They comprise around fifty amino acids connected by peptide bonds, often arranged linearly. Peptides may be similar to proteins, except that proteins have longer chains of amino acids.

Investigations purport that peptides, despite their relatively tiny size, might be involved in a wide variety of physiological activities at an essential level. Because they may particularly target receptors, they have become an important topic of attention in research. Recent developments in peptide synthesis have aimed to produce analogs of endogenous molecules while simultaneously enhancing these compounds' stability, selectivity, and effectiveness.

Peptides and Gut Function

There is a possibility that research peptides might be practical in alleviating a variety of inflammatory disorders that are associated with the gastrointestinal (G.I.) tract. These conditions include ulcerative colitis and gastritis. In addition, findings imply that several chemicals may potentially hasten the healing process in many areas of the gastrointestinal tract, including the small intestine (after successful surgical resection). The following is a list of probable ways by which peptides may assist in the improvement of the ailments that were previously mentioned:

  • Through the modulation of NO levels, healing peptides like BPC-157 have been proposed as a potential means of enhancing the healing process of the esophagus and stomach. An increase in blood flow and the development of new blood vessels are effects of the vasodilator known as NO.
  • BPC-157 has been hypothesized to prevent stomach ulcers by interacting with dopamine and adrenaline signaling pathways.
  • By inhibiting the production of interleukin-6 (IL-6), interleukin-12 (IL-12), tumor-necrotizing factor-alpha (TNF-alpha), and interferon-gamma, the anti-inflammatory tripeptide KPV has been theorized to help decrease inflammation in the digestive tract, primarily in the large intestine (in models of ulcerative colitis).
  • According to research, a different peptide known as ARA-290 seems to potentially reduce TNF-alpha levels in colitis models, resulting in anti-inflammatory properties.

ARA-290 Peptide

Cibinetide and helix B surface peptide (HBSP) is another name for ARA-290, a synthetic example of a peptide consisting of 11 amino acids. The helix B section of erythropoietin (EPO) that interacts with the innate repair receptor (IRR) is the unique portion of EPO intended to be replicated by this particular apparatus. In contrast to EPO, the peptide has been speculated to have a specific affinity for the IRR, which might allow it to perform its function without causing erythropoiesis to be induced.

ARA-290 has been subjected to thorough evaluation in research studies, which have indicated its potential and efficacy in reducing issues linked to type 2 diabetes and small-fiber neuropathy in sarcoidosis.

Preclinical research using mouse models of colonic inflammation has ascertained that it might inhibit the activation of macrophages and lower the release of inflammatory cytokines such as TNF-alpha and IL-1beta.

LL-37 Peptide

LL-37, sometimes called cationic antimicrobial peptide 18 (hCAP18), is the only cathelicidin composed of 37 amino acids. It is an element of the innate immune response, derived from the CAMP gene and responsible for its production. By breaking the cell membranes of bacteria, LL-37 suggests antibacterial capabilities that are speculated to be effective against a wide range of bacteria.

It is believed that LL-37 may have a role in mucosal defense in the gut. The fact that it is expressed in normal gastric tissue and increased in response to infections such as Helicobacter pylori is evidence of its function in the gastrointestinal tract's immune system. Its potential is highlighted because the peptide has been hypothesized to have a bactericidal effect against H. pylori. This action might be practical in managing infections and disorders connected with them, such as gastritis and ulcers.

Research suggests that LL-37 may be a good candidate for targeted adjuvants to strengthen the gut's defensive systems against pathogens. Scientists speculate this is because it is specific, and its expression may increase during infection.

Visit corepeptides.com if you are a researcher interested in further studying peptides' potential in gut health. Please remember that none of the compounds mentioned in this article have been approved for human consumption and should not be acquired by unlicensed individuals.

References

[i] Jelovac, N., Sikirić, P., Rucman, R., Petek, M., Perović, D., Konjevoda, P., Marović, A., Seiwerth, S., Grabarević, Z., Sumajstorcić, J., Dodig, G., & Perić, J. (1998). A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biological psychiatry, 43(7), 511–519. https://doi.org/10.1016/s0006-3223(97)00277-1

[ii] Djakovic, Z., Djakovic, I., Cesarec, V., Madzarac, G., Becejac, T., Zukanovic, G., Drmic, D., Batelja, L., Zenko Sever, A., Kolenc, D., Pajtak, A., Knez, N., Japjec, M., Luetic, K., Stancic-Rokotov, D., Seiwerth, S., & Sikiric, P. (2016). Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME. World journal of gastroenterology, 22(41), 9127–9140. https://doi.org/10.3748/wjg.v22.i41.912

[iii] Hsieh, M. J., Liu, H. T., Wang, C. N., Huang, H. Y., Lin, Y., Ko, Y. S., Wang, J. S., Chang, V. H., & Pang, J. S. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of molecular medicine (Berlin, Germany), 95(3), 323–333. https://doi.org/10.1007/s00109-016-1488-y

[iv] Sikirić, P., Mazul, B., Seiwerth, S., Grabarević, Z., Rucman, R., Petek, M., Jagić, V., Turković, B., Rotkvić, I., Mise, S., Zoricić, I., Jurina, L., Konjevoda, P., Hanzevacki, M., Gjurasin, M., Separović, J., Ljubanović, D., Artuković, B., Bratulić, M., Tisljar, M., … Sumajstorcić, J. (1997). Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress. Digestive diseases and sciences, 42(3), 661–671. https://doi.org/10.1023/a:1018880000644

[v] Sikiric, P., Hahm, K. B., Blagaic, A. B., Tvrdeic, A., Pavlov, K. H., Petrovic, A., Kokot, A., Gojkovic, S., Krezic, I., Drmic, D., Rucman, R., & Seiwerth, S. (2020). Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future. Gut and liver, 14(2), 153–167. https://doi.org/10.5009/gnl18490

[vi] Lojo, N., Rasic, Z., Zenko Sever, A., Kolenc, D., Vukusic, D., Drmic, D., Zoricic, I., Sever, M., Seiwerth, S., & Sikiric, P. (2016). Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats. PloS one, 11(9), e0162590. https://doi.org/10.1371/journal.pone.0162590

[vii] Luger, T. A., & Brzoska, T. (2007). alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52–iii55. https://doi.org/10.1136/ard.2007.079780

[viii] Iwasaki, M., Akiba, Y., & Kaunitz, J. D. (2019). Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Research, 8, F1000 Faculty Rev-1629. https://doi.org/10.12688/f1000research.18039.1

[ix] Lee, A. C., Harris, J. L., Khanna, K. K., & Hong, J. H. (2019). A Comprehensive Review on Current Advances in Peptide Drug Development and Design. International journal of molecular sciences, 20(10), 2383. https://doi.org/10.3390/ijms20102383

[x] Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal transduction and targeted therapy, 7(1), 48. https://doi.org/10.1038/s41392-022- 00904-4

More For You

Jonas Brothers

Jonas Brothers are among the first to use TikTok’s new bulletin board tool

Getty Images

Jonas Brothers among first to test TikTok bulletin boards in new messaging feature

Quick highlights:

  • TikTok is testing a new one-way messaging feature called bulletin boards.
  • Jonas Brothers, People magazine, and Paris Saint-Germain among early testers.
  • The feature mimics Instagram’s broadcast channels but may expand further.
  • Only creators can post; followers can react with emojis but not comment.

TikTok is trialling a new feature called bulletin boards, allowing select creators and brands to send direct broadcast-style messages to their followers, similar to Instagram’s broadcast channels. The Jonas Brothers, football club Paris Saint-Germain, and People magazine are among the first to test the tool, which shows TikTok’s growing focus on creator-fan intimacy beyond its traditional feed.

Keep ReadingShow less
Ryland Headley

Ryland Headley, a 92-year-old man convicted of a 1967 murder following a cold case breakthrough

Avon and Somerset Police

Could cold case killer Ryland Headley have more victims?

Key points

  • Ryland Headley, 92, was convicted in 2023 for the 1967 rape and murder of Louisa Dunne.
  • Modern DNA testing on preserved evidence led to the breakthrough.
  • Headley previously admitted to raping two elderly women and committing multiple burglaries.
  • Police are now working with the NCA and other forces to investigate further possible crimes.
  • Officers describe him as a “dangerous serial offender” whose full history may still be unknown.

Ryland Headley, a 92-year-old man convicted of a 1967 murder following a cold case breakthrough, is now the subject of wider police investigations. Detectives believe he may be responsible for further unsolved crimes, with similarities in method and victim profile suggesting a disturbing pattern. Headley was convicted of raping and murdering 75-year-old Louisa Dunne in Bristol after DNA evidence linked him to the scene more than five decades later. Avon and Somerset Police are now working with the National Crime Agency and other forces to pursue additional leads.

Cold case solved with modern forensics

The murder of Louisa Dunne in June 1967 shocked the Easton community in Bristol. Despite an extensive investigation, no suspect was identified at the time. It wasn’t until a cold case review in 2023 that investigators made a breakthrough.

Keep ReadingShow less
David Joseph

Joseph has chaired several BRIT Awards shows and was an executive producer of the Oscar and BAFTA-winning 2015 documentary Amy.

David Joseph named new CEO of the RSA

THE ROYAL SOCIETY OF ARTS (RSA) has announced the appointment of David Joseph CBE as its next chief executive officer. He will take over the role in September, succeeding Andy Haldane.

Joseph previously served as chairman and CEO of Universal Music UK for 17 years. During his time at the company, he oversaw its transformation into a global exporter of British music and worked with several major international artists.

Keep ReadingShow less
‘Jurassic World Rebirth’ Divides Critics, But Johansson Shines

Scarlett Johansson wins praise in Jurassic World Rebirth as reviews split over story and mutant dinosaurs

Instagram/jurassicworld

‘Jurassic World Rebirth’ review roundup: Scarlett Johansson steals the show but critics call it “the worst Jurassic yet”

Quick highlights:

  • Jurassic World Rebirth, starring Scarlett Johansson and Jonathan Bailey, releases on 4 July.
  • Twitter reactions praise the cast and visuals but criticise the film’s story and lack of emotional depth.
  • Rotten Tomatoes score stands at 54% from 95 reviews; Metacritic rates it 53.
  • Some fans applaud the Spielberg-style thrills, others feel it strays too far with mutant dinosaurs.

Jurassic World Rebirth, the latest addition to the iconic dinosaur saga, has sparked intense debate online ahead of its 4 July release. With Scarlett Johansson and Jonathan Bailey leading the cast, early Twitter reviews show a split audience, some impressed by the action and spectacle, others disappointed by the story’s direction and use of genetically altered dinosaurs.

Keep ReadingShow less
Raducanu Shines in Dominant Start to Wimbledon 2025 Campaign

Raducanu and Jack Draper are making most of the headlines

Getty Images

Raducanu begins Wimbledon campaign with confident win

Key points

  • Emma Raducanu defeated fellow Briton Mimi Xu 6-3, 6-3 in the Wimbledon first round.
  • Xu, 17, was making her Grand Slam debut and appeared overwhelmed early on.
  • Raducanu dropped just three points on serve in the first set.
  • Despite a series of breaks in the second set, Raducanu regained control to seal victory.
  • She described the all-British clash as “difficult” but was pleased with the result.

  • The biggest home assault on Wimbledon for 41 years got off to a great start on Monday when Emma Raducanu triumphed in an all-British clash.

    Keep ReadingShow less